We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
-3.98%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.61B
AUM Growth
-$176M
Cap. Flow
-$7.57M
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.38%
Holding
278
New
8
Increased
76
Reduced
97
Closed
17

Top Buys

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$43.2M
2
TECK icon
Teck Resources
TECK
+$40.4M
3
SMCI icon
Super Micro Computer
SMCI
+$24.4M
4
BN icon
Brookfield
BN
+$19.2M
5
HCA icon
HCA Healthcare
HCA
+$17M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$47M
2
CCK icon
Crown Holdings
CCK
+$38.1M
3
AEM icon
Agnico Eagle Mines
AEM
+$32M
4
SLG icon
SL Green Realty
SLG
+$21.7M
5
KMX icon
CarMax
KMX
+$19.1M

Sector Composition

Rank Sector Weight
1 Technology 18.87%
2 Financials 15.85%
3 Healthcare 13.12%
4 Consumer Discretionary 10.92%
5 Materials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLY icon
26
John Wiley & Sons Class A
WLY
$2.52B
$26.6M 1.02%
707,211
+46,843
+7% +$2.23M
IFF icon
27
International Flavors & Fragrances
IFF
$19.4B
$26.4M 1.01%
290,145
+98,665
+52% +$11.3M
CCEP icon
28
Coca-Cola Europacific Partners
CCEP
$46.5B
$26M 1%
610,442
+68,880
+13% +$3.46M
HD icon
29
Home Depot
HD
$332B
$25.9M 0.99%
93,893
+515
+0.6% +$152K
TJX icon
30
TJX Companies
TJX
$170B
$25.7M 0.99%
414,071
-2,854
-0.7% -$179K
HCA icon
31
HCA Healthcare
HCA
$84.8B
$25.6M 0.98%
139,423
+85,374
+158% +$17M
LMT icon
32
Lockheed Martin
LMT
$134B
$25.6M 0.98%
66,143
-385
-0.6% -$161K
CB icon
33
Chubb
CB
$140B
$25.3M 0.97%
139,282
-483
-0.3% -$91.7K
GSM icon
34
FerroAtlántica
GSM
$628M
$24.8M 0.95%
4,696,380
+317,275
+7% +$1.97M
FNV icon
35
Franco-Nevada
FNV
$41.4B
$24.7M 0.95%
206,700
-3,090
-1% -$388K
SMCI icon
36
Super Micro Computer
SMCI
$19.5B
$24.6M 0.94%
4,462,650
+4,282,150
+2,372% +$24.4M
CL icon
37
Colgate-Palmolive
CL
$72.6B
$24.1M 0.92%
343,076
+17
+0% +$1.33K
LH icon
38
Labcorp
LH
$24.3B
$24M 0.92%
136,679
-580
-0.4% -$119K
BAX icon
39
Baxter International
BAX
$11.6B
$23.7M 0.91%
440,028
+71,975
+20% +$4.33M
DHR icon
40
Danaher
DHR
$135B
$23.7M 0.91%
103,309
-8,598
-8% -$2.1M
BMY icon
41
Bristol-Myers Squibb
BMY
$127B
$23M 0.88%
323,777
-3,240
-1% -$235K
FIS icon
42
Fidelity National Information Services
FIS
$21.5B
$22.9M 0.88%
302,837
-2,369
-0.8% -$221K
PEP icon
43
PepsiCo
PEP
$186B
$22.9M 0.88%
140,038
-2,824
-2% -$487K
JNJ icon
44
Johnson & Johnson
JNJ
$635B
$22.5M 0.86%
137,787
-40
-0% -$6.77K
CVX icon
45
Chevron
CVX
$388B
$22.3M 0.86%
155,544
-385
-0.2% -$58.7K
CSTM icon
46
Constellium
CSTM
$3.96B
$22.2M 0.85%
2,189,545
+57,425
+3% +$761K
ADP icon
47
Automatic Data Processing
ADP
$100B
$21.2M 0.81%
93,905
+2,000
+2% +$472K
AMR icon
48
Alpha Metallurgical Resources
AMR
$1.82B
$21.1M 0.81%
154,450
+45,595
+42% +$6.34M
SGRY icon
49
Surgery Partners
SGRY
$2.06B
$20.9M 0.8%
892,155
+530,910
+147% +$17M
FDX icon
50
FedEx
FDX
$74.5B
$20.2M 0.78%
136,286
-3,917
-3% -$827K

Similar funds

Cannell & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Cannell & Co held 278 positions worth $2.61B, down 6.3% from $2.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Cannell & Co's Q3 2022 filing shows 8 new, 76 increased, 97 reduced and 17 closed positions. Its largest new stake was EQT Corp: 996,050 shares worth $40.6M. The largest sale was AstraZeneca, an estimated $47M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Cannell & Co's largest Q3 2022 buy was EQT Corp: 996,050 shares worth $40.6M.
  • Cannell & Co added most to Teck Resources in Q3 2022, an estimated $40.4M increase.
  • Cannell & Co's biggest Q3 2022 reduction was Crown Holdings, cutting an estimated $38.1M.
  • Cannell & Co fully exited AstraZeneca in Q3 2022, selling an estimated $47M.
  • Cannell & Co's ten largest holdings make up 29% of its $2.61B portfolio in Q3 2022.
  • Cannell & Co opened 8 new positions and closed 17 in Q3 2022.
  • Cannell & Co's portfolio value fell 6.3% quarter-over-quarter to $2.61B.

Based on Cannell & Co's 13F filing for Q3 2022, filed 2 Nov 2022.